Table 2 Change in primary and secondary outcome measures in post-treatment phase relative to baseline

LCQ _Total

5.32

3.04 to 7.60

2.34

− 0.33 to 5.02

6.35

4.07 to 8.63

2.17

− 0.50 to 4.85

0.14

2.657

0.058

LCQ _Phys

1.46

0.74 to 2.18

0.60

− 0.24 to 1.42

1.64

0.92 to 2.36

0.47

− 0.36 to 1.30

0.17

2.49

0.097

LCQ _Psych

1.95

0.92 to 2.99

0.80

− 0.42 to 2.01

2.43

1.39 to 3.46

0.50

− 0.72 to 1.71

0.19

3.36

0.046

LCQ _Soc

1.91

1.00 to 2.81

0.96

− 0.09 to 2.00

2.30

1.39 to 3.20

0.96

− 0.09 to 2.00

0.14

1.84

0.174

VAS

-32.3

-52.1 to -12.4

-5.11

-27.0 to 16.8

-33.4

-53.2 to -13.5

-4.2

-26.1 to 17.1

0.11

2.16

0.103

logC5

1.12

0.53 to 1.78

0.41

− 0.41 to 0.97

--

--

--

--

0.13

2.54

0.094

UTC

-5.00

-7.47 to -2.53

-1.61

-4.34 to 1.11

--

--

--

--

0.15

5.08

0.037